Two antibody panels using multiplexed immunofluorescence were designed for the simultaneous detection of CD8+ T-lymphocytes, CD68+ macrophages, Cytokeratin (CK) for tumor cells, PD-L1 immune checkpoint andKi67 as a proliferation marker (Figure 1A). Here, CD8A is linked to neoplasm.